Eli Lilly: Q2 2026 IPR&D Charge Estimated At $3.02/Share
Acquired IPR&D Charges Estimated At $2.80B Pre-Tax
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Acquired IPR&D Charges Estimated At $2.80B Pre-Tax
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.